Ionis Pharmaceuticals: TD Cowen cuts target price to $53 from $84
IONS•TD Cowen cut its target price for Ionis Pharmaceuticals to $53 from $84.
Related News
Nexon subsidiary Neople signs Tencent publishing deal for Project OVERKILL in China
TCEHY•
Vivid Seats Inc: RBC cuts target price to $4 from $9
SEAT•
KBW raises Allstate target price to $241 from $232
ALL•
Greenfire Resources cut to sell from buy by TD Cowen
GFR•
Moonshot AI reportedly accessed a trove of Nvidia's most advanced chips this summer
NVDA•